Jeffrey S. Parkin

Array ( [id] => 1416947 [patent_doc_number] => 06514731 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens' [patent_app_type] => B1 [patent_app_number] => 08/653226 [patent_app_country] => US [patent_app_date] => 1996-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 12099 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 267 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514731.pdf [firstpage_image] =>[orig_patent_app_number] => 08653226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4149234 [patent_doc_number] => 06103244 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Methods for generating immune responses employing modified vaccinia of fowlpox viruses' [patent_app_type] => 1 [patent_app_number] => 8/651472 [patent_app_country] => US [patent_app_date] => 1996-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 16 [patent_no_of_words] => 65294 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103244.pdf [firstpage_image] =>[orig_patent_app_number] => 651472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4016387 [patent_doc_number] => 05880276 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Purified retroviral constitutive transport enhancer elements that enhance nucleocytoplasmic transport of mRNA, and methods of making and using the elements' [patent_app_type] => 1 [patent_app_number] => 8/638975 [patent_app_country] => US [patent_app_date] => 1996-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 14852 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880276.pdf [firstpage_image] =>[orig_patent_app_number] => 638975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602456 [patent_doc_number] => 06432634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Method, apparatus and kits for sequencing of nucleic acids using multiple dyes' [patent_app_type] => B1 [patent_app_number] => 08/634284 [patent_app_country] => US [patent_app_date] => 1996-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 3634 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432634.pdf [firstpage_image] =>[orig_patent_app_number] => 08634284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3814338 [patent_doc_number] => 05770428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site' [patent_app_type] => 1 [patent_app_number] => 8/627845 [patent_app_country] => US [patent_app_date] => 1996-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 5085 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770428.pdf [firstpage_image] =>[orig_patent_app_number] => 627845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4125687 [patent_doc_number] => 06033672 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Method of stimulating an immune response to caprine arthritis-encephalitis virus (CAEV) in humans through the administration of CAEV immunogens' [patent_app_type] => 1 [patent_app_number] => 8/616854 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11703 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033672.pdf [firstpage_image] =>[orig_patent_app_number] => 616854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254289 [patent_doc_number] => 06207804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Genetically engineered antibody analogues and fusion proteins thereof' [patent_app_type] => 1 [patent_app_number] => 8/575724 [patent_app_country] => US [patent_app_date] => 1995-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 10275 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 324 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207804.pdf [firstpage_image] =>[orig_patent_app_number] => 575724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 891024 [patent_doc_number] => 07344722 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-03-18 [patent_title] => 'Cold-adapted influenza virus' [patent_app_type] => utility [patent_app_number] => 08/573569 [patent_app_country] => US [patent_app_date] => 1995-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20064 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/344/07344722.pdf [firstpage_image] =>[orig_patent_app_number] => 08573569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763239 [patent_doc_number] => 05773010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Low molecular weight allergen obtained from Dermatophagoides farinae' [patent_app_type] => 1 [patent_app_number] => 8/564395 [patent_app_country] => US [patent_app_date] => 1995-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6409 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773010.pdf [firstpage_image] =>[orig_patent_app_number] => 564395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4236461 [patent_doc_number] => 06202654 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Cleaning system' [patent_app_type] => 1 [patent_app_number] => 8/549849 [patent_app_country] => US [patent_app_date] => 1995-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 4605 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/202/06202654.pdf [firstpage_image] =>[orig_patent_app_number] => 549849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4167053 [patent_doc_number] => 06140059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.' [patent_app_type] => 1 [patent_app_number] => 8/448619 [patent_app_country] => US [patent_app_date] => 1995-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 9227 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140059.pdf [firstpage_image] =>[orig_patent_app_number] => 448619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938167 [patent_doc_number] => 05997869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Peptides containing a fusion joint of a chimeric protein encoded by DNA spanning a tumor-associated chromosomal translocation and their use as immunogens' [patent_app_type] => 1 [patent_app_number] => 8/528129 [patent_app_country] => US [patent_app_date] => 1995-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 1 [patent_no_of_words] => 16531 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/997/05997869.pdf [firstpage_image] =>[orig_patent_app_number] => 528129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045787 [patent_doc_number] => 05874565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus' [patent_app_type] => 1 [patent_app_number] => 8/520678 [patent_app_country] => US [patent_app_date] => 1995-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23233 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874565.pdf [firstpage_image] =>[orig_patent_app_number] => 520678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940960 [patent_doc_number] => 05872213 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Identification and characterization of a novel human protein designated integrase interactor 1, that binds specifically to the human immunodeficiency virus type 1 integrase' [patent_app_type] => 1 [patent_app_number] => 8/516801 [patent_app_country] => US [patent_app_date] => 1995-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 10991 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872213.pdf [firstpage_image] =>[orig_patent_app_number] => 516801 [rel_patent_id] =>[rel_patent_doc_number] =>)